Two new studies show no benefit of malaria drug Hydroxychloroquine against Covid-19.

  • Hydroxychloroquine, widely used to treat malaria, had been touted by President Donald Trump as a potential game changer.
  • Mounting evidence from clinical and observational studies suggest that it doesn’t provide any meaningful benefits for COVID-19 patients.
  • In a new study published May 14, researchers in France accessed the effectiveness of hydroxychloroquine in 181 adults who were hospitalized. The drug did not significantly reduce symptoms within 10 days.
  • A study at the Shanghai Jiao Tong University School of Medicine in China included 150 adults with mild or moderate Covid-19. Half received hydroxychloroquine and half did not. There was no difference in recovery between the two groups after 28 days. However, those that were given hydroxychloroquine experienced more adverse events.
Advertisements